Where does Idexx Laboratories Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Idexx Laboratories Inc. ranks #3,969 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Idexx Laboratories Inc. hold?

Idexx Laboratories Inc. holds 91 US utility patents granted between 2015 and 2025, spanning 33 technology areas.

What is Idexx Laboratories Inc.'s Innovation Score?

Idexx Laboratories Inc. has an Innovation Score of 57.2 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Idexx Laboratories Inc. focus on?

Idexx Laboratories Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 70 patents, ranking #211 of 7,863 assignees active in that subclass. Grants appear in 33 CPC subclasses total.

Is Idexx Laboratories Inc.'s patent grant rate increasing or decreasing?

Idexx Laboratories Inc.'s recent grant velocity is +59% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Idexx Laboratories Inc.'s patents?

Idexx Laboratories Inc.'s patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Idexx Laboratories Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Idexx Laboratories Inc.

USPTO PatentsView assignee record - 91 granted patents across 33 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Idexx ranks #3,969 of 49,997 tracked US assignees by granted-patent volume, with 91 patents across 33 technology areas.

#3,969
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.2/100): 18.8
avg claims per patent: +59%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3969 · US Corporation #3,969 · 91 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 91 grants
TOP-DECILE #3,969/49,997
PHOTO-FINISH Esab AB
CPC-FOCUS G01N · 33 areas
INNOV-PAR 57.2/100
CLAIMS-RICH 18.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +59% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Esab AB (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Idexx’s 57.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.6 pts (27%) Velocity 10.0 pts (17%) Breadth 20.3 pts (35%) Claim depth 11.3 pts (20%)

Qualcomm Incorporated · highest

85
AGC Flat Glass… · near

57
Beijing Huamei · near

57
Idexx Laboratories · this assignee

57
Leica Biosystems… · near

57
Mainstream Engineering · near

57
3D Lighting… · lowest

7

What this shows Idexx's Innovation Score is 57.2/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Idexx?

Each dot is one of Idexx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Idexx’s own 18.8 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Idexx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Idexx's grants concentrate

Idexx Laboratories Inc. is a focused PatentsView assignee: 33 CPC subclasses with 76.9% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2015 (15 grants) versus a trough of 2 in 2018. By volume, Idexx sits between Esab AB and Kofax, Inc..

Idexx's three-year grant acceleration

From 2019–2021 to 2022–2024, Idexx Laboratories Inc. moved from 20 to 30 grants (1.50x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Esab AB

91
Evalve

91
Galderma Holding

91
Hover

91
Iqvia

91
JGC Catalysts and…

91
Joyetech Europe H…

91
Kofax

91
Idexx Laboratories ◀

91

What this shows Idexx holds 91 patents at rank #3,969, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Idexx

By rank, the assignees closest to #3,969 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Idexx's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Idexx, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Idexx ranks #211 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (57 here).

AGC Flat Glass North America, Inc. 57 Mainstream Engineering Corporation 57 Leica Biosystems Nussloch GmbH 57 Beijing Huamei, Inc. 57

Similar claim depth

Nearest assignees by average claims per patent (18.8 here).

Kaseya Limited 18.8 avg Whitehead Institute For Biomedical Research 18.8 avg 3shape A/S 18.8 avg Genzyme Corporation 18.8 avg

Idexx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Idexx Laboratories Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	15	16.5%
2016	4	4.4%
2017	4	4.4%
2018	2	2.2%
2019	4	4.4%
2020	8	8.8%
2021	8	8.8%
2022	6	6.6%
2023	9	9.9%
2024	15	16.5%
2025partial year	16	17.6%

Which technologies does Idexx Laboratories Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 70

C07K - Peptides 14

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 13

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

G02B - Optical Elements, Systems OR Apparatus 7

A61B - DIAGNOSIS; SURGERY; Identification 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 5

G06F - Electric Digital Data Processing 5

Y02A - Technologies FOR Adaptation TO Climate Change 4

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 3

Top 15 of 33 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Idexx Laboratories Inc.'s patent record in context - here's where to go next.

Idexx Laboratories Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 76.9% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #3,969 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Idexx Laboratories Inc. against Esab AB, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.